Sufianov, A.,
Bessonova, M.,
Begliarzade, S.,
Kudriashov, V.,
Danilov, A.,
Ilyasova, T.,
Yaolou, W.,
Nafikova, R.,
Beylerli, O. (2023) by airway inflammation, increased responsiveness and changes in airway structure. T
cells, particularly
GUO, X.,
BAI, Y.,
ZHANG, L.,
ZHANG, B.,
DU, Z.,
CAI, B.,
ZAGIDULLIN, N.,
CARVALHO, K.3 (2018) for millions
of deaths every year worldwide. Bone-marrow
mesenchymal stem
cells (BMSCs) transplantation may
CARDIOMYOCYTE DIFFERENTIATION OF MESENCHYMAL STEM CELLS FROM BONE MARROW: NEW REGULATORS AND ITS IMPLICATIONSGuo, X.,
Bai, Y.,
Zhang, L.,
Zhang, B.,
Zagidullin, N.,
Carvalho, K.,
Du, Z.,
Cai, B. (2018) for millions of deaths every year worldwide. Bone-marrow mesenchymal stem
cells (BMSCs) transplantation may
Sufianov, Albert,
Begliarzade, Sema,
Kudriashov, Valentin,
Nafikova, Radmila,
Ilyasova, Tatiana,
Liang, Yanchao (2023) endothelial and parietal
cells to heterogeneous angiogenic signals provided by tissues and organs. Micro
Lu, Enzhou,
Gareev, Ilgiz,
Yuan, Chao,
Liang, Yanchao,
Sun, Jingxian,
Chen, Xin,
Beylerli, Ozal,
Sufianov, Albert,
Zhao, Shiguang,
Yang, Guang (2022) the
cell cycle, and the main site of action is the DNA of
cells, which are common chemotherapeutic drugs
of the expression of non-coding RNAs typical for a
cell type and stage of development reflect transposon activation
Beilerli, A.,
Kudriashov, V.,
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Ilyasova, T.,
Liang, Ya.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) in target
cells (hepatocytes, adipocytes, skeletal muscle
cells), resulting in the termination
of
cell cycle control, apoptosis and resistance to treatment, and the possible use of miRNAs in clinical